Abstract | PURPOSE: METHODS: Women (n=3103) were asked about estrogen (ERT) and progestin plus estrogen (PERT) replacement therapy use at 4 examinations over 9 years. Electrocardiographic QT intervals were measured and corrected for heart rate using the QT Index (QTI) and Bazett's correction. QT prolongation was defined as QTI>110% and a change from baseline of >or=4%. RESULTS: Heart rate corrected QT length was moderately but significantly (p<0.01) greater, and the risk of QT prolongation was nearly twice (Odds Ratio=1.9, 95% Confidence Interval: 1.2-2.0) that in women who used ERT compared with never users. PERT use was not significantly associated with QT length. CONCLUSIONS: The potential for slight increases in QT length over time, and an increased risk of QT prolongation with ERT use identified in this observational study, are important concerns that should be further explored in randomized trials.
|
Authors | Mercedes R Carnethon, Mary S Anthony, Wayne E Cascio, Aaron R Folsom, Pentti M Rautaharju, Duanping Liao, Gregory W Evans, Gerardo Heiss |
Journal | Annals of epidemiology
(Ann Epidemiol)
Vol. 13
Issue 7
Pg. 530-6
(Aug 2003)
ISSN: 1047-2797 [Print] United States |
PMID | 12932629
(Publication Type: Evaluation Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Topics |
- Arteriosclerosis
(etiology)
- Cohort Studies
- Electrocardiography
- Estrogen Replacement Therapy
(adverse effects)
- Female
- Humans
- Long QT Syndrome
(chemically induced, complications, physiopathology)
- Longitudinal Studies
- Middle Aged
- Prospective Studies
- United States
|